Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...
The combination of axi-cel and rituximab showed high efficacy in refractory LBCL, with a 73% complete response rate and 88% overall response rate. Safety was favorable, with no new signals; 96% ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Repeated exercise, or wasting, can change the way key genes work.
Some people are immune to dementia, even if their brain is deteriorating. Cognitive reserve is the secret boost that builds ...
Today Leo takes a look at the new Asus rog Zephyrus G14 with Ryzen 9 4900HS. It is extremely impressive - and today he shows you why. 00:16 Introduction 00:47 Unboxing The G14 01:32 No lighting in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback